Montara Therapeutics, a biotech company pioneering brain-selective therapies for CNS diseases, today announced the closing of a $20 million oversubscribed expansion of its Series Seed financing. The round, which brings Montara’s total seed funding to $28 million, includes increased participation from all existing investors, including founding investor SV Health Investors’ Dementia Discovery Fund, Two Bear Capital, Dolby Family Ventures, and KdT Ventures, along with new investments from BEVC and additional investors.
Congratulations to Kevan Shokat and William Weiss, the UCSF PIs.